APO Research
Talk to an analyst

APO RESEARCH · REPORT

Influenza A Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Influenza A Vaccine Industry Growth and Trends Forecast to 2032

22 December 2025100 pages

Choose your research edition.

Industry ResearchInfluenza A Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza A Vaccine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Influenza A Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza A Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza A Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Influenza A Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Influenza A Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Influenza A Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Influenza A Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Influenza A Vaccine include Changsheng Bio-Technology, Abbott, Sanofi, Novartis, Merck, Sinovac Biotech, Hualan Biological Engineering, GSK and Beijing Tiantan Bio-Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Influenza A Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Influenza A Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Influenza A Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Influenza A Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Influenza A Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Influenza A Vaccine Market by Company

Changsheng Bio-Technology

Abbott

Sanofi

Novartis

Merck

Sinovac Biotech

Hualan Biological Engineering

GSK

Beijing Tiantan Bio-Products

Mitsubishi Tanabe Pharma

Medimmune

Influenza A Vaccine Segment by Type

Intramuscular Vaccine

Nasal Spray Vaccine

Influenza A Vaccine Segment by Application

3-18 Years Old

Above 18 Years Old

Influenza A Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza A Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza A Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza A Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Influenza A Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Influenza A Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Intramuscular Vaccine Table 2. Major Company of Nasal Spray Vaccine Table 3. Global Influenza A Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Influenza A Vaccine Sales by Type (2021-2026) & (k units) Table 5. Global Influenza A Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Influenza A Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Influenza A Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Influenza A Vaccine Price by Type (2021-2026) & (US$/unit) Table 9. Global Influenza A Vaccine Sales by Type (2027-2032) & (k units) Table 10. Global Influenza A Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Influenza A Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Influenza A Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Influenza A Vaccine Price by Type (2027-2032) & (US$/unit) Table 14. North America Influenza A Vaccine Sales by Type (2021-2026) & (k units) Table 15. North America Influenza A Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Influenza A Vaccine Sales by Type (2021-2026) & (k units) Table 17. Europe Influenza A Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Influenza A Vaccine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Influenza A Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Influenza A Vaccine Sales by Type (2021-2026) & (k units) Table 21. Latin America Influenza A Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Influenza A Vaccine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Influenza A Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Influenza A Vaccine Industry Trends Table 25. Influenza A Vaccine Industry Drivers Table 26. Influenza A Vaccine Industry Opportunities and Challenges Table 27. Influenza A Vaccine Industry Restraints Table 28. Global Influenza A Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Influenza A Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Influenza A Vaccine Sales by Company (2021-2026) & (k units) Table 31. Global Influenza A Vaccine Sales Share by Company (2021-2026) Table 32. Global Influenza A Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Influenza A Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Influenza A Vaccine Major Company Production Sites and Headquarters Table 35. Global Influenza A Vaccine Company, Product Type & Application Table 36. Global Influenza A Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Influenza A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Influenza A Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Influenza A Vaccine Sales by Region (2021-2026) & (k units) Table 41. Global Influenza A Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Influenza A Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Influenza A Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Influenza A Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Influenza A Vaccine Sales by Region (2027-2032) & (k units) Table 46. Global Influenza A Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Influenza A Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Influenza A Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Influenza A Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Influenza A Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Influenza A Vaccine Sales by Application (2021-2026) & (k units) Table 52. Global Influenza A Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Influenza A Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Influenza A Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Influenza A Vaccine Price by Application (2021-2026) & (US$/unit) Table 56. Global Influenza A Vaccine Sales by Application (2027-2032) & (k units) Table 57. Global Influenza A Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Influenza A Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Influenza A Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Influenza A Vaccine Price by Application (2027-2032) & (US$/unit) Table 61. North America Influenza A Vaccine Sales by Application (2021-2026) & (k units) Table 62. North America Influenza A Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Influenza A Vaccine Sales by Application (2021-2026) & (k units) Table 64. Europe Influenza A Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Influenza A Vaccine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Influenza A Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Influenza A Vaccine Sales by Application (2021-2026) & (k units) Table 68. Latin America Influenza A Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Influenza A Vaccine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Influenza A Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Changsheng Bio-Technology Company Information Table 72. Changsheng Bio-Technology Business Overview Table 73. Changsheng Bio-Technology Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Changsheng Bio-Technology Influenza A Vaccine Product Portfolio Table 75. Changsheng Bio-Technology Recent Development Table 76. Abbott Company Information Table 77. Abbott Business Overview Table 78. Abbott Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Abbott Influenza A Vaccine Product Portfolio Table 80. Abbott Recent Development Table 81. Sanofi Company Information Table 82. Sanofi Business Overview Table 83. Sanofi Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Sanofi Influenza A Vaccine Product Portfolio Table 85. Sanofi Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Novartis Influenza A Vaccine Product Portfolio Table 90. Novartis Recent Development Table 91. Merck Company Information Table 92. Merck Business Overview Table 93. Merck Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Merck Influenza A Vaccine Product Portfolio Table 95. Merck Recent Development Table 96. Sinovac Biotech Company Information Table 97. Sinovac Biotech Business Overview Table 98. Sinovac Biotech Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Sinovac Biotech Influenza A Vaccine Product Portfolio Table 100. Sinovac Biotech Recent Development Table 101. Hualan Biological Engineering Company Information Table 102. Hualan Biological Engineering Business Overview Table 103. Hualan Biological Engineering Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Hualan Biological Engineering Influenza A Vaccine Product Portfolio Table 105. Hualan Biological Engineering Recent Development Table 106. GSK Company Information Table 107. GSK Business Overview Table 108. GSK Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. GSK Influenza A Vaccine Product Portfolio Table 110. GSK Recent Development Table 111. Beijing Tiantan Bio-Products Company Information Table 112. Beijing Tiantan Bio-Products Business Overview Table 113. Beijing Tiantan Bio-Products Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Beijing Tiantan Bio-Products Influenza A Vaccine Product Portfolio Table 115. Beijing Tiantan Bio-Products Recent Development Table 116. Mitsubishi Tanabe Pharma Company Information Table 117. Mitsubishi Tanabe Pharma Business Overview Table 118. Mitsubishi Tanabe Pharma Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Mitsubishi Tanabe Pharma Influenza A Vaccine Product Portfolio Table 120. Mitsubishi Tanabe Pharma Recent Development Table 121. Medimmune Company Information Table 122. Medimmune Business Overview Table 123. Medimmune Influenza A Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Medimmune Influenza A Vaccine Product Portfolio Table 125. Medimmune Recent Development Table 126. North America Influenza A Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. North America Influenza A Vaccine Sales by Country (2021-2026) & (k units) Table 128. North America Influenza A Vaccine Sales Market Share by Country (2021-2026) Table 129. North America Influenza A Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 130. North America Influenza A Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. North America Influenza A Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Influenza A Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Influenza A Vaccine Market Share by Country (2021-2026) Table 134. North America Influenza A Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Influenza A Vaccine Market Share Forecast by Country (2027-2032) Table 136. Europe Influenza A Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Europe Influenza A Vaccine Sales by Country (2021-2026) & (k units) Table 138. Europe Influenza A Vaccine Sales Market Share by Country (2021-2026) Table 139. Europe Influenza A Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 140. Europe Influenza A Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Influenza A Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Influenza A Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Influenza A Vaccine Market Share by Country (2021-2026) Table 144. Europe Influenza A Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Influenza A Vaccine Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Influenza A Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Influenza A Vaccine Sales by Country (2021-2026) & (k units) Table 148. Asia-Pacific Influenza A Vaccine Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Influenza A Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 150. Asia-Pacific Influenza A Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Influenza A Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Influenza A Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Influenza A Vaccine Market Share by Country (2021-2026) Table 154. Asia-Pacific Influenza A Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Influenza A Vaccine Market Share Forecast by Country (2027-2032) Table 156. Latin America Influenza A Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Latin America Influenza A Vaccine Sales by Country (2021-2026) & (k units) Table 158. Latin America Influenza A Vaccine Sales Market Share by Country (2021-2026) Table 159. Latin America Influenza A Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 160. Latin America Influenza A Vaccine Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Influenza A Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Influenza A Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Influenza A Vaccine Market Share by Country (2021-2026) Table 164. Latin America Influenza A Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Influenza A Vaccine Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Influenza A Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Influenza A Vaccine Sales by Country (2021-2026) & (k units) Table 168. Middle East and Africa Influenza A Vaccine Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Influenza A Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 170. Middle East and Africa Influenza A Vaccine Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Influenza A Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Influenza A Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Influenza A Vaccine Market Share by Country (2021-2026) Table 174. Middle East and Africa Influenza A Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Influenza A Vaccine Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Influenza A Vaccine Distributors List Table 179. Influenza A Vaccine Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Influenza A Vaccine Image Figure 2. Global Influenza A Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Influenza A Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Influenza A Vaccine Sales (2021-2032) & (k units) Figure 5. Intramuscular Vaccine Image Figure 6. Global Intramuscular Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 7. Nasal Spray Vaccine Image Figure 8. Global Nasal Spray Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Influenza A Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Influenza A Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Influenza A Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Influenza A Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Influenza A Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Influenza A Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Influenza A Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Influenza A Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Influenza A Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Influenza A Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Influenza A Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Influenza A Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Influenza A Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. 3-18 Years Old Image Figure 24. Global 3-18 Years Old Sales YoY Growth (2021-2032) & (k units) Figure 25. Above 18 Years Old Image Figure 26. Global Above 18 Years Old Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Influenza A Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Influenza A Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Influenza A Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Influenza A Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Influenza A Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Influenza A Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Influenza A Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Influenza A Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Influenza A Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Influenza A Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Influenza A Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Influenza A Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Influenza A Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Influenza A Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Influenza A Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Influenza A Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Influenza A Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Influenza A Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Influenza A Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Influenza A Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Influenza A Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Influenza A Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Influenza A Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Influenza A Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Influenza A Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Influenza A Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Influenza A Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Influenza A Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Influenza A Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Influenza A Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Influenza A Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Influenza A Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Influenza A Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Influenza A Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Intramuscular Vaccine
  • Nasal Spray Vaccine
Applications
  • 3-18 Years Old
  • Above 18 Years Old
Companies covered
  • Changsheng Bio-Technology
  • Abbott
  • Sanofi
  • Novartis
  • Merck
  • Sinovac Biotech
  • Hualan Biological Engineering
  • GSK
  • Beijing Tiantan Bio-Products
  • Mitsubishi Tanabe Pharma
  • Medimmune

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Influenza A Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Influenza A Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Influenza A Vaccine Market by Type
  6. 1.3.1 Intramuscular Vaccine
  7. 1.3.2 Nasal Spray Vaccine
  8. 1.4 Global Influenza A Vaccine Market Size by Type
  9. 1.4.1 Global Influenza A Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Influenza A Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Influenza A Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Influenza A Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Influenza A Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Influenza A Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Influenza A Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Influenza A Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Influenza A Vaccine Industry Trends
  2. 2.2 Influenza A Vaccine Industry Drivers
  3. 2.3 Influenza A Vaccine Industry Opportunities and Challenges
  4. 2.4 Influenza A Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Influenza A Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Influenza A Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Influenza A Vaccine Price (2021-2026)
  4. 3.4 Global Influenza A Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Influenza A Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Influenza A Vaccine Company, Product Type & Application
  7. 3.7 Global Influenza A Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Influenza A Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Influenza A Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Influenza A Vaccine Tier 1, Tier 2, and Tier 3
4 Influenza A Vaccine Regional Status and Outlook
  1. 4.1 Global Influenza A Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Influenza A Vaccine Historic Market Size by Region
  3. 4.2.1 Global Influenza A Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Influenza A Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Influenza A Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Influenza A Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Influenza A Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Influenza A Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Influenza A Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Influenza A Vaccine by Application
  1. 5.1 Influenza A Vaccine Market by Application
  2. 5.1.1 3-18 Years Old
  3. 5.1.2 Above 18 Years Old
  4. 5.2 Global Influenza A Vaccine Market Size by Application
  5. 5.2.1 Global Influenza A Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Influenza A Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Influenza A Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Influenza A Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Influenza A Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Influenza A Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Influenza A Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Influenza A Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Changsheng Bio-Technology
  2. 6.1.1 Changsheng Bio-Technology Company Information
  3. 6.1.2 Changsheng Bio-Technology Business Overview
  4. 6.1.3 Changsheng Bio-Technology Influenza A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Changsheng Bio-Technology Influenza A Vaccine Product Portfolio
  6. 6.1.5 Changsheng Bio-Technology Recent Developments
  7. 6.2 Abbott
  8. 6.2.1 Abbott Company Information
  9. 6.2.2 Abbott Business Overview
  10. 6.2.3 Abbott Influenza A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Abbott Influenza A Vaccine Product Portfolio
  12. 6.2.5 Abbott Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Influenza A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Influenza A Vaccine Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Influenza A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Influenza A Vaccine Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Influenza A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck Influenza A Vaccine Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Sinovac Biotech
  32. 6.6.1 Sinovac Biotech Company Information
  33. 6.6.2 Sinovac Biotech Business Overview
  34. 6.6.3 Sinovac Biotech Influenza A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sinovac Biotech Influenza A Vaccine Product Portfolio
  36. 6.6.5 Sinovac Biotech Recent Developments
  37. 6.7 Hualan Biological Engineering
  38. 6.7.1 Hualan Biological Engineering Company Information
  39. 6.7.2 Hualan Biological Engineering Business Overview
  40. 6.7.3 Hualan Biological Engineering Influenza A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hualan Biological Engineering Influenza A Vaccine Product Portfolio
  42. 6.7.5 Hualan Biological Engineering Recent Developments
  43. 6.8 GSK
  44. 6.8.1 GSK Company Information
  45. 6.8.2 GSK Business Overview
  46. 6.8.3 GSK Influenza A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GSK Influenza A Vaccine Product Portfolio
  48. 6.8.5 GSK Recent Developments
  49. 6.9 Beijing Tiantan Bio-Products
  50. 6.9.1 Beijing Tiantan Bio-Products Company Information
  51. 6.9.2 Beijing Tiantan Bio-Products Business Overview
  52. 6.9.3 Beijing Tiantan Bio-Products Influenza A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Beijing Tiantan Bio-Products Influenza A Vaccine Product Portfolio
  54. 6.9.5 Beijing Tiantan Bio-Products Recent Developments
  55. 6.10 Mitsubishi Tanabe Pharma
  56. 6.10.1 Mitsubishi Tanabe Pharma Company Information
  57. 6.10.2 Mitsubishi Tanabe Pharma Business Overview
  58. 6.10.3 Mitsubishi Tanabe Pharma Influenza A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mitsubishi Tanabe Pharma Influenza A Vaccine Product Portfolio
  60. 6.10.5 Mitsubishi Tanabe Pharma Recent Developments
  61. 6.11 Medimmune
  62. 6.11.1 Medimmune Company Information
  63. 6.11.2 Medimmune Business Overview
  64. 6.11.3 Medimmune Influenza A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Medimmune Influenza A Vaccine Product Portfolio
  66. 6.11.5 Medimmune Recent Developments
7 North America by Country
  1. 7.1 North America Influenza A Vaccine Sales by Country
  2. 7.1.1 North America Influenza A Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Influenza A Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Influenza A Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Influenza A Vaccine Market Size by Country
  6. 7.2.1 North America Influenza A Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Influenza A Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Influenza A Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Influenza A Vaccine Sales by Country
  2. 8.1.1 Europe Influenza A Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Influenza A Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Influenza A Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Influenza A Vaccine Market Size by Country
  6. 8.2.1 Europe Influenza A Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Influenza A Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Influenza A Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Influenza A Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Influenza A Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Influenza A Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Influenza A Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Influenza A Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Influenza A Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Influenza A Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Influenza A Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Influenza A Vaccine Sales by Country
  2. 10.1.1 South America Influenza A Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Influenza A Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Influenza A Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Influenza A Vaccine Market Size by Country
  6. 10.2.1 South America Influenza A Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Influenza A Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Influenza A Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Influenza A Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Influenza A Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Influenza A Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Influenza A Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Influenza A Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Influenza A Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Influenza A Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Influenza A Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Influenza A Vaccine Value Chain Analysis
  2. 12.1.1 Influenza A Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Influenza A Vaccine Production Mode & Process
  7. 12.2 Influenza A Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Influenza A Vaccine Distributors
  10. 12.2.3 Influenza A Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst